511 related articles for article (PubMed ID: 27933214)
1. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.
Horak P; Fröhling S; Glimm H
ESMO Open; 2016; 1(5):e000094. PubMed ID: 27933214
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
Beigh MM
Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
[TBL] [Abstract][Full Text] [Related]
3. Clinical Next Generation Sequencing for Precision Medicine in Cancer.
Dong L; Wang W; Li A; Kansal R; Chen Y; Chen H; Li X
Curr Genomics; 2015 Aug; 16(4):253-63. PubMed ID: 27006629
[TBL] [Abstract][Full Text] [Related]
4. When should we order a next generation sequencing test in a patient with cancer?
Colomer R; Mondejar R; Romero-Laorden N; Alfranca A; Sanchez-Madrid F; Quintela-Fandino M
EClinicalMedicine; 2020 Aug; 25():100487. PubMed ID: 32775973
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
6. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
LeBlanc VG; Marra MA
Cancers (Basel); 2015 Sep; 7(3):1925-58. PubMed ID: 26404381
[TBL] [Abstract][Full Text] [Related]
8. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
Khotskaya YB; Mills GB; Mills Shaw KR
Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
[TBL] [Abstract][Full Text] [Related]
10. Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing.
Park ST; Kim J
Int Neurourol J; 2016 Nov; 20(Suppl 2):S76-83. PubMed ID: 27915479
[TBL] [Abstract][Full Text] [Related]
11. Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.
Pant S; Weiner R; Marton MJ
Front Oncol; 2014; 4():78. PubMed ID: 24860780
[TBL] [Abstract][Full Text] [Related]
12. Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.
Lier A; Penzel R; Heining C; Horak P; Fröhlich M; Uhrig S; Budczies J; Kirchner M; Volckmar AL; Hutter B; Kreutzfeldt S; Endris V; Richter D; Wolf S; Pfütze K; Neumann O; Buchhalter I; Morais de Oliveira CM; Singer S; Leichsenring J; Herpel E; Klauschen F; Jost PJ; Metzeler KH; Schulze-Osthoff K; Kopp HG; Kindler T; Rieke DT; Lamping M; Brandts C; Falkenhorst J; Bauer S; Schröck E; Folprecht G; Boerries M; von Bubnoff N; Weichert W; Brors B; Lichter P; von Kalle C; Schirmacher P; Glimm H; Fröhling S; Stenzinger A
JCO Precis Oncol; 2018 Nov; 2():1-13. PubMed ID: 35135162
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities for next-generation sequencing in companion diagnostics.
Lin E; Chien J; Ong FS; Fan JB
Expert Rev Mol Diagn; 2015 Feb; 15(2):193-209. PubMed ID: 25249308
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
Ji Y; Si Y; McMillin GA; Lyon E
Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Mosele MF; Westphalen CB; Stenzinger A; Barlesi F; Bayle A; Bièche I; Bonastre J; Castro E; Dienstmann R; Krämer A; Czarnecka A; Meric-Bernstam F; Michiels S; Miller R; Normanno N; Reis-Filho J; Remon J; Robson M; Rouleau E; Scarpa A; Serrano C; Mateo J; André F
Ann Oncol; 2024 May; ():. PubMed ID: 38834388
[TBL] [Abstract][Full Text] [Related]
16. Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer.
Kyrochristos ID; Ziogas DE; Goussia A; Glantzounis GK; Roukos DH
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752125
[TBL] [Abstract][Full Text] [Related]
17. Value-based genomics.
Gong J; Pan K; Fakih M; Pal S; Salgia R
Oncotarget; 2018 Mar; 9(21):15792-15815. PubMed ID: 29644010
[TBL] [Abstract][Full Text] [Related]
18. Precision diagnostics in cancer: Predict, prevent, and personalize.
Crabtree JS; Miele L
Prog Mol Biol Transl Sci; 2022; 190(1):39-56. PubMed ID: 36008001
[TBL] [Abstract][Full Text] [Related]
19. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing in precision oncology: challenges and opportunities.
Kruglyak KM; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
